Abstract | BACKGROUND: OBJECTIVE: METHODS:
Tixocortol pivalate has been incorporated in our standard 1-52 patch test series since November 1992. We reviewed the histories and patch test results in all patients tested with the standard 1-52 series from November 1992 to December 1996. RESULTS: CONCLUSION:
|
Authors | M E Lutz, R A el-Azhary, L E Gibson, A F Fransway |
Journal | Journal of the American Academy of Dermatology
(J Am Acad Dermatol)
Vol. 38
Issue 5 Pt 1
Pg. 691-5
(May 1998)
ISSN: 0190-9622 [Print] United States |
PMID | 9591812
(Publication Type: Journal Article)
|
Chemical References |
- Adrenal Cortex Hormones
- Allergens
- Anti-Allergic Agents
- Anti-Bacterial Agents
- Anti-Inflammatory Agents
- hydrocortisone-17-butyrate
- Triamcinolone
- hydrocortisone acetate
- Budesonide
- hydrocortisone valerate
- tixocortol pivalate
- Neomycin
- Hydrocortisone
|
Topics |
- Administration, Topical
- Adrenal Cortex Hormones
(adverse effects)
- Adult
- Aged
- Aged, 80 and over
- Allergens
(adverse effects)
- Anti-Allergic Agents
(adverse effects)
- Anti-Bacterial Agents
(adverse effects)
- Anti-Inflammatory Agents
(adverse effects)
- Budesonide
(adverse effects)
- Cross Reactions
- Dermatitis, Allergic Contact
(etiology)
- Europe
- Facial Dermatoses
(chemically induced)
- Female
- Humans
- Hydrocortisone
(adverse effects, analogs & derivatives)
- Male
- Middle Aged
- Minnesota
- Neomycin
(adverse effects)
- Patch Tests
- Prevalence
- Risk Factors
- Triamcinolone
(adverse effects)
|